RET 05-26NCT07615699
Morpho-functional Evaluation of the Retina and Choroid Using Multimodal Imaging in Healthy Subjects and Patients With Retino-choroidal Diseases
StatusNot Yet Recruiting
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Start date pushed from Oct 2026 to Dec 2026
- Eligibility criteria expanded, about 7 words
- Secondary endpoints: details revised at 2 of 5 entries
- Notable Start date: Jul 1, 2026 to Oct 2026v2
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Change from baseline in retinal thickness measured by OCT
Timeframe: Baseline, 12, 24, 36, 48, and 60 months.
Secondary (5)
Change from baseline in choroidal thickness measured by OCT
Change from baseline in retinal and/or choroidal vascular density measured by OCTA
Change from baseline in retinal sensitivity measured by microperimetry
Change from baseline in cone density measured by adaptive optics
Change from baseline in qualitative retinal and choroidal imaging features
Arms and interventions
Patients with Retino-Choroidal Diseases
Subjects of any gender, aged 6 years or older, diagnosed with any type of retino-choroidal pathology. Participants in this cohort will undergo multi-device structural and functional retinal/choroidal imaging monitoring over a 5-year follow-up period.
Healthy Controls
Healthy subjects of any gender, aged 6 years or older, who do not present with any active or historical retino-choroidal pathology. This group serves as a baseline comparison to evaluate normal morpho-functional retinal and choroidal trajectories over the 5-year study period.